Safety of AI-Powered Virtual Assistant in Outpatient Management of Heart Failure

Recruiting now · Not applicable

Conditions studied: Heart Failure

In brief

The aim of this pilot randomized study is to examine whether integrating the SIRIO-HF virtual assistant (VA) into the outpatient management of participants recently discharged from hospital with a new diagnosis of heart failure (HF), may reduce the need for regular medical assessment and the healthcare burden, reduce variability in healthcare, and meet with participant satisfaction, without compromising participant safety and overall care quality.

Key facts

Study ID

NCT06400927

Run by

East and North Hertfordshire NHS Trust

People needed

60

Starts

2024-05-07

Expected to finish

2027-09-13

Last updated by the study team

2024-07-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years
• Newly diagnosed HF with New York Heart Association class II-III symptoms at discharge

You may not qualify if…

• Known prior history of HF
• Severe comorbidities that could affect protocol adherence, in the opinion of the investigator
• Alternative diagnosis for symptoms such as chronic obstructive pulmonary disease
• Dementia or other cognitive impairment
• Currently involved in another interventional clinical trial

Where it is running

• East and North Hertfordshire NHS Trust — Stevenage, Hertfordshire, United Kingdom (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.